New Safety Information - Food and Drug Administration

Close

GMP
FDA Academy
Downloadables
Bids and Awards
Careers
FAQs
Report
Contact Us

Menu

GMP
FDA Academy
Downloadables
Bids and Awards
Careers
FAQs
Report
Contact Us

Home
About FDA
Transparency
Issuances
Services
- eServices
- ePortal
- ePortal2
- Doctrack
- RRDportal

Menu

Home
About FDA
Transparency
Issuances
Services
- eServices
- ePortal
- ePortal2
- Doctrack
- RRDportal

New Safety Information

2019

Incorrect Use of Anti-Fungal Corticosteroid Combination Therapy
Unsafe use of glutathione as skin lightening agent
SGLT2 inhibitors and risk of necrotizing fasciitis of the perineum (Fournier’s gangrene)
Fluoroquinolones and risk of aortic aneurysm and dissection

Quick Menus

Recent Posts

FDA Advisory No.2022-1223 || Public Health Warning Against the Purchase…
ITB No. 2022-0078-AFS || Procurement of Janitorial and Maintenance Services…
Announcement || FDA SYSTEM MAINTENANCE 01 July 2022
NP-SVP(A)-2022-028-DTQAL || Procurement of Food Reference Material of DTQAL

Quick Links

Department of Health (DOH)
U.S Food and Drug Administration (U.S FDA)
Department of Information and Communications Technology (DICT)
Department of Science and Technology (DOST)
Anti-Red Tape Authority (ARTA)

Contact Information

Address:

Civic Drive Filinvest Corporate City

Alabang, Muntinlupa City

Tel. no: (02) 8857-1900 local 1000

[email protected]

Landline:

(02) 8857-1900
local 1000
(02) 8842-5635

Mobile:

09617709691
09616845994
09610574926

Email: [email protected]

Copyright © 2022. All Rights Reserved.

Shares